Effect of hot water extract powder of radish green on body fat reduction; a randomized, double-blinded, placebo-controlled clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0011935

Enrollment

100

Registered

2026-05-06

Start date

2025-01-22

Completion date

Unknown

Last updated

2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Treatment group - Study drug : hot water extract powder of radish green 900mg(hot water extract powder of radish green 500mg/day), etc. - Once a day, 2 capsules, take it with wate

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. A person who consented to participate in this study and voluntarily signed a written consent form 2. Adult men and women between the ages of 19 and 75 3. A person with a body mass index(BMI) of 23 to 30 kg/m2

Exclusion criteria

Exclusion criteria: 1. Subjects with severe cerebrovascular disease(cerebral infarction, cerebral hemorrhage, etc.), heart disease(angina pectoris, myocardial infarction, heart failure, arrhythmia requiring treatment), or malignant tumor within the last 6 months(however, those with a history of cerebrovascular or heart disease who are clinically stable may participate at the investigator's discretion.) 2. Patients with uncontrolled hypertension (blood pressure of 160/100mmHg or higher, measurement standard after subject resting for 10 minutes) 3. Those with uncontrolled diabetes (fasting blood sugar of 160mg/dl or higher) 4. Those who are being treated for hypothyroidism or hyperthyroidism 5. A person whose creatinine measurement value is more than twice the upper limit of normal of the research institution 6. A person whose AST (GOT) or ALT (GPT) measurement value is more than 3 times the upper limit of normal of the research institution 7. A person who has been taking drugs that affect weight within the past month(including absorption inhibitors, appetite suppressants, weight-loss health functional foods/supplements, psychiatric medications such as antidepressants, beta-blockers, diuretics, contraceptives, steroids, and female hormones) 8. Those who have participated in a commercial obesity program within the last 3 months 9. Those who have participated or plan to participate in other clinical trials within the last month 10. Alcohol Abuse 11. Non-smoking within 3 months 12. Those who are pregnant/lactating or plan to become pregnant during the human application test period 13. A person who has an allergic reaction to component foods 14. A person who is judged to be unsuitable by the tester for other reasons

Design outcomes

Primary

Measure	Time frame
body fat mass(kg) through DEXA(Dual Energy X-Ray Absorptiometry)	—

Secondary

Measure	Time frame
hs-CRP;Adiponectin;Body Mass Index(BMI);body weight;Waist Circumference;Hip Circumference;Waist to Hip Ratio(WHR);Body fat percentage (%), lean body mass (kg) through DEXA;Lipids(Tryglyceride, HDL-C, calculated LDL-C, total cholesterol);FFA(Free Fatty Acids)	—

Countries

Korea, Republic of

Contacts

Public ContactHan Seongho

Dong-A University

handsomdr@hanmail.net+82-51-240-2591

Outcome results